TrialJournal of neuro-oncology2009

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.

R M Zuniga et al.PubMed ↗Publisher ↗

No numbers read from the abstract.